🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effects of Upper Extremity Low Volume HIIT in Heart Failure

RecruitingNAAges 18 Years - anyAllTarsus University
NCT06754475 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study was planned to investigate the effects of upper extremity low-volume high-intensity interval training (LV-HIIT) on physical and cognitive function in patients with heart failure with preserved ejection fraction(HFpEF).The research was planned as a randomized controlled trial. Patients with clinically stable HFpEF at cardiology clinic will be included in the study. These cases will be randomly divided into two groups: intervention group and control grup. After 8 weeks intervention physical functions before and after treatment; functional exercise capacity, arm exercise capacities , peripheral muscle strength , fatigue cognitive functions; anxiety and depression and fear of movement will be evaluated.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinical condition stable for ≥4 weeks. * New York Heart Association functional classification I-II to III * Over 18 years old Exclusion Criteria: History of CABG surgery * Unstable angina pectoris * Severe arrhythmia * Acute pericarditis, endocarditis, myocarditis * Severe left ventricular failure (EF \<40%) * Acute pulmonary embolism * History of syncope * Dissecting aneurysm * Thrombophlebitis * Orthopedic disorders that may interfere with exercise * Uncontrolled hypertension, severe pulmonary arterial hypertension * Moderate-severe valve disease * Decompensated Congestive Heart Failure * Electrolyte abnormalities * Hypertrophic Cardiomyopathy
💊

What it tests

  • Low-volume, high-intensity interval training
  • Standart medical treatment
📍

Where

2 sites
Tarsus University, TARSUS, Mersin
Mersin, Turkey (Türkiye)
Nurel Ertürk, TARSUS, Mersin
Yenişehir, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy